scorecardresearch
Add as a preferred source on Google
Friday, February 27, 2026
TopicDrug trials

Topic: drug trials

Health ministry eases drug trial rules. Test licences scrapped, CDSCO approval timelines cut by half

Under earlier rules, drugmakers had to get a test licence from CDSCO to manufacture small quantities of drugs for research, examination or analysis.

Trial in India finds 2-drug combinations 5 times more effective than single pill in controlling hypertension

Amlodipine & perindopril, amlodipine & indapamide, and perindopril & indapamide achieved blood pressure control in 70 percent of patients to less than 140/90 mm Hg in six months.

Cancer ‘disappears’, every patient in remission — New York drug trial shows astonishing results

Fourteen patients with rectal cancer carrying a specific genetic mutation were rid of the disease using immunotherapy, without need for chemotherapy, radiation or surgery.

Pharma firms and diagnostics developers need to unite. They are catalysts for saving lives

Studies of drugs like remdesivir and hydroxychloroquine were underpowered and small, and the results were conflicting and, in many cases, inconclusive.

Brazil trial shows Sinovac vaccine above 50% effective, but researchers delay full results

Sinovac is betting on a successful vaccine to inoculate more people around the world, especially in developing countries that will have limited access to the Pfizer and Moderna shots.

New antibody therapy may lower Covid hospitalisations, Eli Lilly says

Interim results from Lilly and AbCellera’s treatment trial found a 1.7% hospitalisation rate compared with a 6% rate among people on a placebo, a 72% reduction in risk and no deaths.

Pune’s Serum Institute set to start human trials of Oxford Covid vaccine, gets regulator nod

DCGI decision to allow human trials on 1,600 participants in India is based on data submitted by SII on first two phases of Oxford University trials.

UK company Synairgen declares clinical trial of protein treatment for Covid as successful

Synairgen said its SNG001 formulation greatly reduced the number of hospitalised Covid-19 patients, who progressed from requiring oxygen to requiring ventilation.

Why there is a big debate over accuracy and results of Covid anti-body tests

The anti-body test is crucial to understanding Covid-19 & the virus that causes it. It can tell how many people potentially have some level of immunity.

HIV drug combo approved by ICMR for coronavirus treatment fails clinical trials in China

Anti-HIV drugs Lopinavir and Ritonavir were administered to treat two Italian tourists in India who had tested positive for the coronavirus infection.

On Camera

Women’s sports are missing out on a key ingredient of success—women viewers

Women are positioned as peripheral consumers of lifestyle products adjacent to sports, not core consumers of sports entertainment. This represents a massive market inefficiency.

After Bharat Taxi, Cooperation Ministry plans insurance sector entry via IFFCO-Tokio

After launching Bharat Taxi, the ministry explores offering insurance products across cooperative banks via IFFCO-Tokio with cooperative banks as corporate agents.

Navy, Germany’s TKMS wrap up cost negotiations for new submarines, P-75I deal likely early next fiscal

It is estimated the deal would eventually work out to cost around $9 bn at least for 6 submarines—negotiated down by India. Original bid by state-run MDL & TKMS was over Rs 1.2 lakh cr.

No country is ever fully sovereign. Cold War era taught India its real meaning

India’s fraught neighbourhood places multiple constraints on its strategic choices. It leaves no time to take a deep breath, lean back and reset.